Andrew Shao

Andrew Shao serves as the senior vice-president of global regulatory and scientific affairs at Niagen Bioscience, a company that specializes in NAD+ supplements. He recently responded to new research on NAD+ levels, emphasizing that while the findings may shift perceptions, they do not fundamentally change the importance of understanding NAD+ dynamics in tissue, particularly in the context of consumer health and wellness.